CRISM Therapeutics Corporation (AIM:CRTX)
London
· Delayed Price · Currency is GBP · Price in GBX 10.62
+0.62 (6.20%)
Apr 28, 2025, 4:16 PM GMT+1
CRISM Therapeutics Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2014 - 2018 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2014 - 2018 |
| Cash & Equivalents | 1.86 | 3.44 | 2.89 | 4.93 | 2.04 | 0.3 | Upgrade
|
| Cash & Short-Term Investments | 1.86 | 3.44 | 2.89 | 4.93 | 2.04 | 0.3 | Upgrade
|
| Cash Growth | -68.51% | 19.06% | -41.42% | 141.49% | 580.01% | -69.53% | Upgrade
|
| Other Receivables | 0.44 | - | - | 0.08 | 0 | 0.02 | Upgrade
|
| Receivables | 0.44 | - | - | 0.08 | 0 | 0.02 | Upgrade
|
| Inventory | - | - | - | - | 0.15 | 0.21 | Upgrade
|
| Prepaid Expenses | - | 0.32 | 0.05 | - | 0.11 | 0.14 | Upgrade
|
| Other Current Assets | - | - | 20.91 | 18.05 | - | - | Upgrade
|
| Total Current Assets | 2.3 | 3.76 | 23.85 | 23.07 | 2.31 | 0.67 | Upgrade
|
| Property, Plant & Equipment | 0.06 | - | - | - | 0.33 | 20.67 | Upgrade
|
| Long-Term Investments | - | - | - | - | 3.85 | - | Upgrade
|
| Other Intangible Assets | 0.05 | - | - | - | 17.24 | - | Upgrade
|
| Total Assets | 2.42 | 3.76 | 23.85 | 23.07 | 23.73 | 21.34 | Upgrade
|
| Accounts Payable | 0.15 | 0.37 | 0.11 | 0.71 | 0.22 | 0.27 | Upgrade
|
| Accrued Expenses | 0.08 | 0.06 | 0.51 | - | 0.44 | 0.44 | Upgrade
|
| Other Current Liabilities | 0.12 | 0.09 | 0.15 | 0.12 | 0 | 0.03 | Upgrade
|
| Total Current Liabilities | 0.35 | 0.52 | 0.76 | 0.83 | 0.67 | 0.73 | Upgrade
|
| Other Long-Term Liabilities | - | - | - | - | 0.1 | 0.12 | Upgrade
|
| Total Liabilities | 0.35 | 0.52 | 0.76 | 0.83 | 0.77 | 0.85 | Upgrade
|
| Common Stock | 68.97 | 63.43 | 67.05 | 59.41 | 58.92 | 52.48 | Upgrade
|
| Additional Paid-In Capital | 3.36 | 3.36 | 3.55 | 3.16 | 3.13 | 3.62 | Upgrade
|
| Retained Earnings | -0.61 | -63.55 | -33.64 | -27.71 | -26.72 | -26.39 | Upgrade
|
| Comprehensive Income & Other | -69.65 | - | -13.88 | -12.63 | -12.38 | -9.22 | Upgrade
|
| Shareholders' Equity | 2.07 | 3.24 | 23.09 | 22.24 | 22.96 | 20.49 | Upgrade
|
| Total Liabilities & Equity | 2.42 | 3.76 | 23.85 | 23.07 | 23.73 | 21.34 | Upgrade
|
| Net Cash (Debt) | 1.86 | 3.44 | 2.89 | 4.93 | 2.04 | 0.3 | Upgrade
|
| Net Cash Growth | -68.51% | 19.06% | -41.42% | 141.49% | 580.01% | - | Upgrade
|
| Net Cash Per Share | 0.16 | 0.40 | 0.33 | 0.57 | 0.31 | 0.07 | Upgrade
|
| Filing Date Shares Outstanding | 32.68 | 8.71 | 8.71 | 8.62 | 8.62 | 4.8 | Upgrade
|
| Total Common Shares Outstanding | 32.68 | 8.71 | 8.71 | 8.62 | 8.62 | 4.8 | Upgrade
|
| Working Capital | 1.95 | 3.24 | 23.09 | 22.24 | 1.64 | -0.06 | Upgrade
|
| Book Value Per Share | 0.06 | 0.37 | 2.65 | 2.58 | 2.66 | 4.27 | Upgrade
|
| Tangible Book Value | 2.02 | 3.24 | 23.09 | 22.24 | 5.72 | 20.49 | Upgrade
|
| Tangible Book Value Per Share | 0.06 | 0.37 | 2.65 | 2.58 | 0.66 | 4.27 | Upgrade
|
| Machinery | - | - | - | - | 3.05 | - | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.